NGM·Healthcare·$183M·#89 / 520 in Healthcare
BNR Burning Rock Biotech Limited
66SOLID
CATEGORY BREAKDOWN
GROWTH7
QUALITY66
STABILITY98
VALUATION100
GOVERNANCE55
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+4.6%
7
> 50% strong
Gross Margin
Revenue retained after direct costs
74.7%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
202 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
8.1%
94
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.3x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
-6
16
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
4.0%
32
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-92.0%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE BNR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when BNR's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.